US Patent Issued to Pfizer on Aug. 11 for "Diacylglycerol acyl transferase 2 inhibitors" (Massachusetts, Connecticut, Rhode Island, California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,696, issued on Aug. 11, was assigned to Pfizer Inc. (New York).

"Diacylglycerol acyl transferase 2 inhibitors" was invented by Markus Boehm (Mansfield, Mass.), Shawn Cabral (Groton, Conn.), Matthew S. Dowling (Old Lyme, Conn.), Kentaro Futatsugi (Qunicy, Mass.), Kim Huard (Berkeley, Calif.), Esther Cheng Yin Lee (Newton, Mass.), Allyn T. Londregan (Barrington, R.I.), Jana Polivkova (Mystic, Conn.), David A. Price (Concord, Mass.) and Qifang Li (Stonington, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases li...